Tuberculosis: Stop It with Effective Treatment
R. Santosh Kumar *
GITAM Institute of Pharmacy, GITAM (Deemed to be University) Visakhapatnam, Andhra Pradesh, India.
Divya Pushp
GITAM Institute of Pharmacy, GITAM (Deemed to be University) Visakhapatnam, Andhra Pradesh, India.
*Author to whom correspondence should be addressed.
Abstract
Aim: Tuberculosis is one of the oldest human diseases, dating back over 17,000 years based totally on molecular proof. Despite modern diagnostic and treatment approaches, people continue to suffer from tuberculosis, and it tops the list of ten deadly infectious diseases in the world, second only to the Human Immunodeficiency Virus. TB is a worldwide pandemic, as per World Health Organization (WHO).It tops the causes of death among HIV-positive individuals. In this review we assess the challenges faced due to tuberculosis and its management and the strategies adopted to tackle it.Because of the dearth of number one health-care infrastructure in rural regions of several states which includes Health care provided privately not regulated nicely, which ends up in First- and second-line anti-TB drugs are widely used irrationally; infection with human immune deficiency virus; loss of political will; and, The most crucial, the corrupt management are all fundamental demanding situations in India's combat against tuberculosis. Another rising danger to TB eradication is multidrug-resistant tuberculosis (MDR-TB), which is the outcome of a failing or deteriorating TB control programme. The World Health Organization's "STOP TB" policy aims to eradicate tuberculosis as a public health hazard by 2050.
Keywords: Tuberculosis, LTBI, line probe assays, LAMP, COVID -19, RNTCP, fusion deposition modelling